Rebuilding the atrophied brain: 6-month nasal esketamine therapy expands key frontal and hippocampal regions and reduces serum neurofilament levels in patients with major depressive disorder. A proof-of-concept study of the depTesk (DEPression treatment with ESKetamine) study

重建萎缩的大脑：为期 6 个月的鼻用艾司氯胺酮疗法可扩大关键的额叶和海马区域，并降低重度抑郁症患者的血清神经丝水平。这是 depTesk（艾司氯胺酮治疗抑郁症）研究的概念验证性研究。